Shenzhen Neptunus Bioengineering Co., Ltd. (SHE:000078)
2.610
+0.090 (3.57%)
May 30, 2025, 3:04 PM CST
SHE:000078 Revenue
Shenzhen Neptunus Bioengineering had revenue of 7.38B CNY in the quarter ending March 31, 2025, a decrease of -8.81%. This brings the company's revenue in the last twelve months to 29.60B, down -14.31% year-over-year. In the year 2024, Shenzhen Neptunus Bioengineering had annual revenue of 30.32B, down -16.75%.
Revenue (ttm)
29.60B
Revenue Growth
-14.31%
P/S Ratio
0.23
Revenue / Employee
3.58M
Employees
8,264
Market Cap
6.87B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 30.32B | -6.10B | -16.75% |
Dec 31, 2023 | 36.42B | -1.42B | -3.74% |
Jan 1, 2023 | 37.83B | -3.22B | -7.84% |
Jan 1, 2022 | 41.05B | 1.03B | 2.58% |
Dec 31, 2020 | 40.02B | -1.47B | -3.54% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Jan 1, 2018 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |